Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

15 Jan 2016 07:00

RNS Number : 9230L
Allied Minds PLC
15 January 2016
 

 

15 JANUARY 2016

 

 

Allied Minds plc (the "Company" or the "Group")

Directorate Change

Appointment of Independent New Non-Executive Director

----------

Jill Smith, Former Chairman, CEO and President of DigitalGlobe Inc, today joins the Board of Directors at Allied Minds as an Independent Non-Executive Director, bringing a wealth of expertise to help oversee the Company's growing portfolio of life-science and technology companies as they commercialize innovations from top U.S. universities and federal research institutions.

Allied Minds' digital and technology businesses will benefit from Ms. Smith's experience at DigitalGlobe, a provider of satellite imagery products and services to governments and companies world-wide. As Chairman, CEO and President, she led DigitalGlobe's successful growth and expansion and took it public in 2009.

As an international business leader for over 25 years, including 16 years as CEO of private and public companies in the technology and information services markets, Ms. Smith is well-placed to advise Allied Minds' growing portfolio of subsidiaries.

Ms Smith will serve on the Audit Committee.

Boston (January 15, 2016) - Allied Minds (LSE: ALM), an innovative U.S. science and technology development and commercialization company, today announced the appointment, effective immediately, of Jill Smith, the former Chairman, CEO and President of DigitalGlobe Inc. (NYSE:DGI), to its Board as an Independent Non-Executive Director. At DigitalGlobe Inc., Ms. Smith delivered over five-fold revenue growth in her nearly 6 years as CEO through market diversification and international expansion. She grew DGI's market capitalization to more than $1.5 billion, and took the company public in 2009. Under her leadership, DGI also won a multi-billion dollar contract, the largest in its history, with the US Government, successfully launched two next generation satellites and established DigitalGlobe as a global leader in earth imagery and geospatial solutions.

Previously, Ms. Smith served as President and CEO of eDial, Inc, a private VoIP collaboration company, and of SRDS, L.P. a private business-to-business publishing company. Prior to this, she also served as COO of Micron Electronics, Inc. setting the multi-billion dollar PC business on a path to profitable growth and leading preparations for the IPO of the hosting subsidiary, HostPro. She co-founded Treacy & Company LLC, a consulting and boutique investment business in 1995. In 1985, Smith started her career at Bain & Company, a global management consulting firm, where she worked in London and Boston and rose to Partner before leaving to join Sara Lee Corporation in Paris, France, as Vice President in the personal products group.Ms. Smith currently serves on the board of Endo International (NASDAQ: ENDP) a global specialty pharmaceutical company, and Hexagon (NASDAQ Stockholm: HEXA B) a leading provider of information technologies and geospatial solutions. She also serves on the board of JM Huber, a global leader in engineered materials, and several private companies serving the information and technology markets. 

Her distinctive expertise is in global expansion and business transformation, helping companies at various stages of growth develop strategies and deploy resources to exploit market opportunities. This will be a valuable asset for Allied Minds as it continues to expand and develop its portfolio of companies engaged in commercializing innovations developed at top U.S. academic and federally funded research institutions. 

Chris Silva, Chief Executive Officer of Allied Minds, commented:

"We welcome Jill to the Board at this important time in Allied Mind's growth. As many of our high tech subsidiaries approach commercialisation, her experience in developing strategies for establishing and capturing markets, especially at innovative and fast growing businesses, will be extremely valuable. She brings a wealth of knowledge and experience to our expanding portfolio and we look forward to working with her as we take the Group into the next phase of its development."

Jill Smith commented:

"I am very excited to be joining Allied Minds at what is clearly a transformational time for the Company. I look forward to working with the Board and the management team to help to deliver the next phase of growth."As noted above, Ms. Smith has held directorships in two publicly quoted companies during the previous five years, including Endo International (NASDAQ: ENDP), and Hexagon (NASDAQ Stockholm: HEXA B). Ms. Smith will serve as a member of the Audit Committee. Jeffrey Rohr (Chair) and Rick Davis will also continue to serve as members of the Audit Committee. There are no further details in relation to Ms. Smith's appointment which require disclosure pursuant to paragraph 9.6.13 of the Listing Rules of the Financial Conduct Authority.

More information about Allied Minds can be found at www.alliedminds.com. About Allied MindsAllied Minds (LSE: ALM) is an innovative U.S. science and technology development and commercialization company. Operating since 2006, Allied Minds forms, funds, manages and builds products and businesses based on innovative technologies developed at leading U.S. universities and federal research institutions. Allied Minds serves as a diversified holding company that supports its businesses and product development with capital, central management and shared services. More information about the Boston-based company can be found at www.alliedminds.com

For more information, please contact:

 

Allied Minds plc www.alliedminds.com

Peter Dolan, Non-Executive Chairman

+1 617 419 1800

 

Chris Silva, Chief Executive Officer

+1 617 419 1800

 

Citigate Dewe Rogerson

 

Patrick Donovan/Rob Newman +442076389571,

alliedminds@CitigateDR.co.uk

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABIMATMBTBBPF
Date   Source Headline
31st Jan 20173:55 pmRNSTotal Voting Rights
30th Jan 201712:02 pmRNSPrice Monitoring Extension
3rd Jan 20172:48 pmRNSHolding(s) in Company
3rd Jan 20172:11 pmRNSTotal Voting Rights
13th Dec 20167:00 amRNSFormation of Signature Medical, Inc.
9th Dec 20165:04 pmRNSHolding(s) in Company
7th Dec 20164:34 pmRNSHolding(s) in Company
6th Dec 20165:05 pmRNSHolding(s) in Company
6th Dec 20165:04 pmRNSHolding(s) in Company
2nd Dec 20167:00 amRNSResults of equity placing
1st Dec 20164:50 pmRNSProposed Equity Placing
23rd Nov 20167:00 amRNSHawkEye 360 Raises $11m in Series A Financing
21st Nov 20167:00 amRNSFormation of Vatic Materials, Inc.
18th Nov 20163:15 pmRNSBlock Listing Six Monthly Return
11th Nov 20165:17 pmRNSHolding(s) in Company
24th Oct 20167:00 amRNSPrecision Biopsy Raises $5.0 Million
17th Oct 201612:07 pmRNSSecond Price Monitoring Extn
17th Oct 201612:02 pmRNSPrice Monitoring Extension
29th Sep 20167:00 amRNSAllied Minds & GE Ventures Form Strategic Alliance
8th Sep 201612:02 pmRNSPrice Monitoring Extension
31st Aug 20165:11 pmRNSTotal Voting Rights
25th Aug 20167:00 amRNSHalf-year Report
22nd Aug 20167:00 amRNSAllied Minds Secures $20m Debt Facility from SVB
22nd Aug 20167:00 amRNSAllied Minds' Subsidiary ABLS II Raises $15m
1st Aug 20167:00 amRNSSciFluor Enters Clinical Trial Stage
29th Jul 201610:30 amRNSTotal Voting Rights
13th Jul 201610:02 amRNSDirector/PDMR Shareholding
13th Jul 201610:01 amRNSDirector/PDMR Shareholding
13th Jul 201610:01 amRNSDirector/PDMR Shareholding
13th Jul 201610:00 amRNSDirector/PDMR Shareholding
7th Jul 20167:00 amRNSLong Term Incentive Plan - Listing Application
30th Jun 20167:00 amRNSTotal Voting Rights
22nd Jun 20164:41 pmRNSSecond Price Monitoring Extn
22nd Jun 20164:35 pmRNSPrice Monitoring Extension
14th Jun 20162:38 pmRNSDirector/PDMR Shareholding
13th Jun 20165:18 pmRNSDirector/PDMR Shareholding
31st May 20164:44 pmRNSBlocklisting Six Monthly Return
26th May 20165:23 pmRNSResult of AGM
26th May 20167:00 amRNSAGM Statement
25th May 20167:00 amRNSABLS II Completes Drug Feasibility Programme
13th May 20167:00 amRNSDirector/PDMR Shareholding
10th May 20164:30 pmRNSLong Term Incentive Plan
28th Apr 201612:33 pmRNSHolding(s) in Company
26th Apr 20167:00 amRNSAllied Minds Raises $80m for ABLS Capital
25th Apr 20167:00 amRNSAnnual Financial Report
19th Apr 20167:00 amRNSAppointment of Joint Broker
16th Mar 20167:00 amRNSABLS agrees license with NYU
10th Feb 20164:40 pmRNSSecond Price Monitoring Extn
10th Feb 20164:36 pmRNSPrice Monitoring Extension
9th Feb 20164:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.